Updated Jul 16, 2026
Baynes Roy D. has filed 7 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $7.99M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-01 | NTRA | Natera, Inc. | A — Grant or award | 75 | — | |
| 2026-07-01 | NTRA | Natera, Inc. | A — Grant or award | 1.6K | — | |
| 2026-06-16 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 4.5K | $50.00 | $225K |
| 2026-06-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 4.5K | $21.38 | $96K |
| 2026-05-21 | TVTX | Travere Therapeutics, Inc. | A — Grant or award | 4.0K | $0.00 | |
| 2026-05-07 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 4.5K | $46.65 | $210K |
| 2026-05-07 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 4.5K | $18.27 | $82K |
| 2026-05-04 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 9.8K | $44.22 | $431K |
| 2026-05-04 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 9.8K | $6.82 | $66K |
| 2026-04-29 | NTRA | Natera, Inc. | A — Grant or award | 83 | — | |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 6.8K | $42.12 | $284K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale | 26.0K | $41.07 | $1.07M |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 6.8K | $17.11 | $115K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 4.5K | $21.38 | $96K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 4.5K | $18.27 | $82K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 9.0K | $15.43 | $139K |
| 2026-04-16 | TVTX | Travere Therapeutics, Inc. | M — Option exercise | 8.0K | $17.94 | $144K |
| 2026-04-07 | TVTX | Travere Therapeutics, Inc. | S — Open-market sale [10b5-1] | 10.0K | $33.00 | $330K |
| 2026-04-07 | TVTX | Travere Therapeutics, Inc. | M — Option exercise [10b5-1] | 10.0K | $26.52 | $265K |
| 2026-02-04 | NTRA | Natera, Inc. | A — Grant or award | 70 | — |
Baynes Roy D. is a corporate insider — currently tracked as Insider of Natera, Inc. (NTRA). InsiderAlpha tracks every SEC Form 4 filing in real time.
7 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 12 open-market sales ($7.99M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Baynes Roy D. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.